- Home
- FPF vs GPCR Comparison
FPF vs GPCR Comparison
Compare FPF & GPCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FPF
- GPCR
- Stock Information
- Founded
- FPF 2013
- GPCR 2016
- Country
- FPF United States
- GPCR United States
- Employees
- FPF N/A
- GPCR N/A
- Industry
- FPF Trusts Except Educational Religious and Charitable
- GPCR
- Sector
- FPF Finance
- GPCR
- Exchange
- FPF Nasdaq
- GPCR Nasdaq
- Market Cap
- FPF 1.1B
- GPCR 1.1B
- IPO Year
- FPF N/A
- GPCR 2023
- Fundamental
- Price
- FPF $18.95
- GPCR $20.12
- Analyst Decision
- FPF
- GPCR Strong Buy
- Analyst Count
- FPF 0
- GPCR 9
- Target Price
- FPF N/A
- GPCR $75.63
- AVG Volume (30 Days)
- FPF 186.7K
- GPCR 903.2K
- Earning Date
- FPF 01-01-0001
- GPCR 08-06-2025
- Dividend Yield
- FPF 8.08%
- GPCR N/A
- EPS Growth
- FPF N/A
- GPCR N/A
- EPS
- FPF N/A
- GPCR N/A
- Revenue
- FPF N/A
- GPCR N/A
- Revenue This Year
- FPF N/A
- GPCR N/A
- Revenue Next Year
- FPF N/A
- GPCR N/A
- P/E Ratio
- FPF N/A
- GPCR N/A
- Revenue Growth
- FPF N/A
- GPCR N/A
- 52 Week Low
- FPF $13.91
- GPCR $13.22
- 52 Week High
- FPF $18.09
- GPCR $45.37
- Technical
- Relative Strength Index (RSI)
- FPF 62.01
- GPCR 62.03
- Support Level
- FPF $18.86
- GPCR $18.46
- Resistance Level
- FPF $18.99
- GPCR $19.46
- Average True Range (ATR)
- FPF 0.11
- GPCR 1.04
- MACD
- FPF 0.00
- GPCR 0.41
- Stochastic Oscillator
- FPF 83.33
- GPCR 94.74
About FPF First Trust Intermediate Duration Preferred & Income Fund of Beneficial Interest
First Trust Inter Dur Pref& Income Fund is a diversified, closed-end management investment company. Its primary investment objective is to seek a high level of current income. Further, it has a secondary objective of capital appreciation. The Fund invests in the traditional preferred securities, hybrid preferred securities, floating rate & fixed-to-floating rate preferred securities, debt securities, convertible securities, and contingent convertible securities issued by U.S. and non-U.S. companies. Its investment portfolio includes industries such as Banks, Insurance, Capital Markets, Electric Utilities, Oil, Gas & Consumable Fuels, Food Products, and others.
About GPCR Structure Therapeutics Inc.
Structure Therapeutics Inc is a clinical-stage biopharmaceutical company developing novel oral small-molecule therapeutics to treat a wide range of chronic diseases with unmet medical needs. Its differentiated technology platform leverages both structure-based drug discovery and expertise in computational chemistry to discover and develop small molecule therapeutics against G-protein coupled receptors (GPCRs). The group operates and manages its business as one reportable and operating segment, which is the business of research and development of medicines that target chronic diseases with unmet medical needs.